TMEM196 Activators encompass a variety of chemical compounds that indirectly stimulate the functional activity of TMEM196 by manipulating diverse signaling pathways and cellular processes. For instance, Forskolin and 8-Bromo-cAMP function by increasing cAMP levels, which in turn activate PKA. This kinase has the potential to phosphorylate TMEM196, thereby enhancing its cellular function. Similarly, PMA, an activator of PKC, may also indirectly stimulate TMEM196 by promoting its phosphorylation, a common regulatory mechanism for protein activation. Calcium ionophores like Ionomycin raise intracellular calcium levels, which could activate calcium-dependent kinases that might target TMEM196 for activation through phosphorylation. Conversely, Okadaic Acid prevents the dephosphorylation of proteins by inhibiting phosphatases PP1 and PP2A, potentially maintaining TMEM196 in an active state. Epigallocatechin gallate (EGCG) adds another layer of regulation by inhibiting competing kinases, potentially shifting the equilibrium toward pathways that activate TMEM196.
PI3K inhibitors, LY294002 and Wortmannin, disrupt AKT signaling, potentially inducing cellular responses that activate TMEM196 through intricate compensatory mechanisms. The presence of essential metal ions like Zinc and Magnesium may also modulate TMEM196 activity, especially if its function is contingent upon these ions as cofactors. Sphingosine-1-phosphate (S1P) activates G protein-coupled receptors, leading to signaling events that could culminate in the activation of TMEM196 via downstream effectors. Lastly, Thapsigargin, by hindering the SERCA pump, causes an increase in cytosoliccalcium, a condition that can trigger calcium-dependent kinases and potentially enhance the activity of TMEM196. Collectively, these chemical activators orchestrate a symphony of biochemical signals that converge to elevate the functional activity of TMEM196, ensuring that it performs its cellular role more effectively without the need for upregulation at the transcriptional or translational level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can lead to the activation of PKA (protein kinase A). PKA then phosphorylates target proteins, potentially including TMEM196, thereby enhancing its function within the cell. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP acts as a cAMP analog, resisting enzymatic degradation and thus sustaining PKA activation. Sustained PKA activity could enhance the phosphorylation and activation of TMEM196 if it is a PKA substrate. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate a wide array of proteins. TMEM196 might be activated by PKC-mediated phosphorylation, which could regulate its cellular functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases that may phosphorylate and activate TMEM196. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases prevents dephosphorylation of proteins, which could lead to sustained activation of TMEM196 if it is regulated by phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain protein kinases. By inhibiting competitive pathways, it may shift the signaling balance towards pathways that activate TMEM196. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling. Disruption of this pathway can result in compensatory responses in the cell that might activate TMEM196. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, similar in function to LY294002, and may indirectly lead to TMEM196 activation through the same compensatory cellular mechanisms. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a divalent cation that can act as a cofactor for several enzymes and may be involved in the direct or indirect activation of TMEM196 if it requires such a cofactor for its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages with G protein-coupled receptors to activate downstream signaling cascades. Such cascades could lead to the activation of TMEM196 through complex signal transduction mechanisms. | ||||||